Sean Jeffries Ph.D.
Net Worth

Last updated:

What is Sean Jeffries Ph.D. net worth?

The estimated net worth of Dr. Sean Jeffries Ph.D. is at least $1,389,089 as of 30 Mar 2021. He owns shares worth $15,769 as insider and has received compensation worth at least $1,373,320 in Design Therapeutics, Inc..

What is the salary of Sean Jeffries Ph.D.?

Dr. Sean Jeffries Ph.D. salary is $343,330 per year as Chief Operating Officer in Design Therapeutics, Inc..

How old is Sean Jeffries Ph.D.?

Dr. Sean Jeffries Ph.D. is 45 years old, born in 1980.

What stocks does Sean Jeffries Ph.D. currently own?

As insider, Dr. Sean Jeffries Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Design Therapeutics, Inc. (DSGN) Chief Operating Officer 3,050 $5.17 $15,769

What does Design Therapeutics, Inc. do?

Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.

Sean Jeffries Ph.D. insider trading

Design Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 3,050 $20 $61,000

Design Therapeutics key executives

Design Therapeutics, Inc. executives and other stock owners filed with the SEC:

  • Dr. João Siffert (62) Pres, Chief Executive Officer & Director
  • Dr. Sean Jeffries Ph.D. (45) Chief Operating Officer